Maintenance of Remission With Budesonide Effervescent Tablets vs. Placebo in Eosinophilic Esophagitis

Condition:   Eosinophilic Esophagitis
Interventions:   Drug: Budesonide effervescent 0.5mg tablet twice daily;   Drug: Budesonide effervescent 1mg tablet twice daily;   Drug: Placebo effervescent tablet twice daily
Sponsor:   Dr. Falk Pharma GmbH
Not yet recruiting – verified July 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.